201 related articles for article (PubMed ID: 31283789)
1. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.
Suzuki L; Ten Kate FJC; Gotink AW; Stoop H; Doukas M; Nieboer D; Spaander MCW; van Lanschot JJB; van Wijnhoven BPL; Koch AD; Bruno MJ; Looijenga LHJ; Biermann K
PLoS One; 2019; 14(7):e0219494. PubMed ID: 31283789
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
4. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging.
de Gouw DJJM; Rijpkema M; de Bitter TJJ; Baart VM; Sier CFM; Hernot S; van Dam GM; Nagtegaal ID; Klarenbeek BR; Rosman C; van der Post RS
Mol Diagn Ther; 2020 Apr; 24(2):191-200. PubMed ID: 32048177
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers predicting lymph node metastasis in early esophageal cancer.
Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
[TBL] [Abstract][Full Text] [Related]
6. The association between histological subtypes and lymph node metastasis and prognosis in early esophageal cancer: a population-based study.
Lin JP; Chen XF; Zhou H; Zhuang FN; He H; Chen WJ; Wang F; Liu SY
Eur J Cancer Prev; 2024 Mar; 33(2):152-160. PubMed ID: 37991237
[TBL] [Abstract][Full Text] [Related]
7. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
Trivedi A; Cartun RW; Ligato S
Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
9. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.
Lee L; Ronellenfitsch U; Hofstetter WL; Darling G; Gaiser T; Lippert C; Gilbert S; Seely AJ; Mulder DS; Ferri LE
J Am Coll Surg; 2013 Aug; 217(2):191-9. PubMed ID: 23659947
[TBL] [Abstract][Full Text] [Related]
10. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
11. P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
van Olphen SH; Biermann K; Shapiro J; Wijnhoven BP; Toxopeus EL; van der Gaast A; Stoop HA; van Lanschot JJ; Spaander MC; Bruno MJ; Looijenga LH
Ann Surg; 2017 Feb; 265(2):347-355. PubMed ID: 28059963
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
[TBL] [Abstract][Full Text] [Related]
13. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
Ramay FH; Vareedayah AA; Visrodia K; Iyer PG; Wang KK; Eluri S; Shaheen NJ; Reddy R; Martin LW; Greenwald BD; Edwards MA
Ann Surg Oncol; 2019 Mar; 26(3):714-731. PubMed ID: 30607765
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
15. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
16. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.
Nobel TB; Barbetta A; Hsu M; Tan KS; Sihag S; Bains MS; Jones DR; Molena D
J Am Coll Surg; 2019 Oct; 229(4):366-373. PubMed ID: 31108196
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of T1b esophageal adenocarcinoma patients.
Tian J; Prasad GA; Lutzke LS; Lewis JT; Wang KK
Gastrointest Endosc; 2011 Dec; 74(6):1201-6. PubMed ID: 22000793
[TBL] [Abstract][Full Text] [Related]
18. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
[TBL] [Abstract][Full Text] [Related]
19. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
Gotink AW; van de Ven SEM; Ten Kate FJC; Nieboer D; Suzuki L; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Schoon EJ; van Lijnschoten I; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
Endoscopy; 2022 Feb; 54(2):109-117. PubMed ID: 33626582
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]